Related Experiment Video
Updated: Jul 2, 2026

Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus (MRSA)
Published on: February 9, 2011
Molecular epidemiology and clinical course of PVL-positive MRSA CC398 infections
Kristýna Brodíková1, Ivana Koláčková1, Miroslava Htoutou Sedláková2,3
1Department of Public Health, Faculty of Medicine, Masaryk University, Kamenice 753/5, Brno, 625 00, Czech Republic.
Abstract:
Methicillin-resistant Staphylococcus aureus (MRSA) clonal complex 398 (CC398) carrying the lukS-PV/lukF-PV genes encoding the Panton-Valentine leukocidin (PVL) production is emerging as a concerning pathogen in the Czech Republic and Europe. This study aimed to investigate the clinical significance, epidemiology, and genetic characteristics of MRSA CC398 strains carrying the PVL genes. A total of 24 MRSA CC398 isolates were obtained from patients with skin and soft tissue infections. DNA was extracted from all isolates, and PCR amplification was used to confirm the presence of the mecA gene for methicillin resistance and the SA442 fragment for S. aureus identification. The affiliation to CC398 and the presence of the lukS-PV/lukF-PV genes were also confirmed by PCR. Sequencing was performed for all isolates to further characterize their genetic composition, including antibiotic resistance and virulence profiles. The isolates exhibited a multi-drug resistance profile, including resistance to beta-lactams and tetracyclines. Virulence factors such as immune evasion cluster genes and biofilm-forming genes were present in all isolates. These findings highlight the growing prevalence and spread of MRSA CC398 in community and healthcare settings and its ability to cause recurrent and difficult-to-treat skin and soft tissue infections. Clinicians should be aware of its presence, particularly in patients from regions where it is endemic, to enable appropriate antibiotic therapy and infection control measures.
Insights
Emerging Panton-Valentine leukocidin (PVL)-producing Methicillin-resistant Staphylococcus aureus (MRSA) CC398 strains are causing difficult skin infections. This study details their genetic traits and resistance, urging clinical awareness for effective treatment.
Area of Science:
- Microbiology
- Infectious Diseases
- Genetics
Background:
- Methicillin-resistant Staphylococcus aureus (MRSA) clonal complex 398 (CC398) producing Panton-Valentine leukocidin (PVL) is an emerging threat.
- This pathogen is increasingly identified in the Czech Republic and Europe.
Purpose of the Study:
- To investigate the clinical significance, epidemiology, and genetic characteristics of PVL-positive MRSA CC398.
- To understand the resistance and virulence profiles of these emerging strains.
Main Methods:
- Collected 24 MRSA CC398 isolates from patients with skin and soft tissue infections.
- Utilized PCR to confirm methicillin resistance (mecA), S. aureus identification, CC398 affiliation, and PVL genes (lukS-PV/lukF-PV).
- Performed DNA sequencing for comprehensive genetic characterization, including antibiotic resistance and virulence factors.
Main Results:
- All isolates were multi-drug resistant, showing resistance to beta-lactams and tetracyclines.
- Presence of immune evasion cluster genes and biofilm-forming genes confirmed in all isolates.
- MRSA CC398 isolates demonstrated significant virulence potential.
Conclusions:
- MRSA CC398 strains carrying PVL genes are prevalent and cause recurrent, challenging skin and soft tissue infections.
- Findings underscore the need for clinical awareness and appropriate infection control measures.
- Early detection and targeted antibiotic therapy are crucial for managing these infections.
Related Concept Videos
Clinical Significance of Antibiotic Resistance
Mechanism of Antibiotic Resistance in MRSA
Bacterial Meningitis II: Pathophysiology
Bacterial Meningitis I: Introduction
Determinants of Bacterial Pathogenicity and Virulence
Bacterial Meningitis
